表示10–1819结果
KPV is a synthetic tripeptide fragment derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH). It exerts regulatory effects on inflammatory signaling via melanocortin receptor activation and NF-κB pathway modulation in experimental models. KPV is used in research investigating epithelial integrity, cytokine balance, and immune-mediated stress responses.
MOTS-c is a mitochondria-derived research peptide composed of 16 amino acids and encoded within the mitochondrial 12S rRNA gene. Preclinical studies show that MOTS-c plays a role in cellular metabolism and mitochondrial homeostasis by activating AMPK signaling pathways. Due to its unique mitochondrial origin, MOTS-c is widely used in metabolic, aging, and energy regulation research, particularly in studies focused on stress adaptation and mitochondrial signaling mechanisms.
NAD⁺ (nicotinamide adenine dinucleotide) is an essential cellular coenzyme that plays a central role in redox metabolism and energy production. It functions as a key electron carrier, cycling between NAD⁺ and NADH to support mitochondrial oxidative phosphorylation and glycolytic energy transfer in experimental models. Beyond metabolism, NAD⁺ acts as a required substrate for sirtuins and PARP enzymes, which are involved in DNA repair, gene expression, cellular stress response, and aging-related pathways. As a result, NAD⁺ is widely used in research focused on mitochondrial health, muscle metabolism, neuroprotection, cellular resilience, and longevity mechanisms.
Retatrutide 10 mg is a next-generation triple-agonist peptide developed by Eli Lilly that simultaneously activates GLP-1, GIP, and glucagon receptors. This advanced multi-receptor approach distinguishes retatrutide from earlier weight-management compounds by targeting appetite control, insulin regulation, energy expenditure, and fat oxidation together, making it a key focus in metabolic and obesity research.
Retatrutide 30 mg is a next-generation triple-agonist peptide developed by Eli Lilly that simultaneously activates GLP-1, GIP, and glucagon receptors. This advanced multi-receptor approach distinguishes retatrutide from earlier weight-management compounds by targeting appetite control, insulin regulation, energy expenditure, and fat oxidation together, making it a key focus in metabolic and obesity research.
Semax is a synthetic heptapeptide derived from the ACTH(4-10) fragment, developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Unlike parent ACTH, Semax does not stimulate adrenal steroidogenesis. Registered as a drug in Russia since 1994 for ischemic stroke and cognitive impairment, its research focuses on BDNF/NGF upregulation, neuroprotection in ischemia models, and attention enhancement. Western evidence is largely preclinical; human data derives mostly from Russian-language clinical publications.
TB-500 (Thymosin Beta-4) is a research peptide representing a 43-amino-acid sequence of Thymosin Beta-4, an actin-binding protein involved in cytoskeletal organization and tissue regeneration. Preclinical studies indicate that TB-500 supports cell migration, angiogenesis, and actin polymerization by regulating the β-actin/G-actin cycle and associated growth factor signaling. It is widely used in research focused on wound repair, cellular motility, and peptide-mediated regenerative mechanisms.
Tesamorelin is a stabilized synthetic analog of growth hormone–releasing hormone (GHRH 1–44) featuring a trans-3-hexenoic acid modification that improves peptide stability. In experimental settings, tesamorelin binds to GHRH receptors to stimulate endogenous growth hormone synthesis and secretion. It is widely used in endocrine and metabolic research focused on peptide stability, receptor binding kinetics, and modulation of the somatotropic (GH) axis.
Tirzepatide is a synthetic dual-incretin peptide that mimics the activity of GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)—two hormones released by the gut after food intake. By activating both pathways, tirzepatide supports blood glucose regulation, appetite suppression, improved insulin response, and fat metabolism, making it a major focus in metabolic, diabetes, and weight-management research.
结束的内容
结束的内容
没有一个帐户吗？ 注册
